Compass Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
BCYC
Bicycle Therapeutics plc |
$8.37 | $577.12 M | -2.11 | 305 |
CRVS
Corvus Pharmaceuticals, Inc. |
$7.19 | $536.50 M | -6.67 | 31 |
FDMT
4D Molecular Therapeutics, Inc. |
$8.55 | $399.75 M | -2.42 | 227 |
FULC
Fulcrum Therapeutics, Inc. |
$9.22 | $497.64 M | -7.8 | 45 |
GOSS
Gossamer Bio, Inc. |
$2.57 | $583.23 M | -4.2 | 144 |
KALV
KalVista Pharmaceuticals, Inc. |
$11.85 | $598.20 M | -3.01 | 150 |
LXRX
Lexicon Pharmaceuticals, Inc. |
$1.41 | $512.39 M | -4.41 | 103 |
MNPR
Monopar Therapeutics Inc. |
$99.39 | $614.16 M | -25.92 | 14 |
OCGN
Ocugen, Inc. |
$1.77 | $554.34 M | -9.34 | 95 |
OMER
Omeros Corporation |
$4.58 | $311.02 M | -1.94 | 202 |